-
Importantly, we found a region of density that is present in the active structure but not the inactive structure that is the right size for FDA-approved drugs for certain forms of hypertension.
#riociguat#Adempas@BayerUS 7/npic.twitter.com/IpUxb3X63s
Prikaži ovu nit -
#PulmonaryHypertension pts frequently receive#Anticoagulant After our previous work on#DDI between#PDE5 inh and#Rivaroxaban or#Apixaban, happy to share our last work on the potential#DDI between#riociguat and#DOACs https://www.ncbi.nlm.nih.gov/pubmed/31411766@CTEPHAdvisor@ThromboAdviserPrikaži ovu nit -
Important
#riociguat study by
colleague Lisa Mielniczuk, editorial by @DrStephenArcher showing improved RV form / function: will we see the same w/#vericiguat in the#VICTORIAtrial enrolling pts w/#heartfailure?@CVC_UAlberta@texhern@coconnormd@JavedButler1@lamcardiohttps://twitter.com/CJC_JCC/status/1039271417366409216 …
-
NDA for
#Riociguat Granted Priority Review by@US_FDA http://ow.ly/jR4FF -
#Bayer has raced to the FDA with its application for#riociguat, a promising candidate for pulmonary hypertension.....http://bit.ly/12rdlVW -
#ACR2018 Dr. Distler's presents Phase 2 data of Riociguat in early#scleroderma. Like previous 2 trials, skin score was no different in Riociguat & Placebo group but were clear trends favoring#Riociguat for retarding disease progression.@ACRheum@BayerPharma#Bayer#SaveRheum -
Very interesting fundamental data about
#riociguat effect on#endothelium in#cteph@CTEPHAdvisorhttps://twitter.com/GendronNico/status/1155070423698223106 … -
#Riociguat improves endothelial cells’ function in#CTEPH.#pulmCC https://hubs.ly/H0khJC60 pic.twitter.com/VRZlNS7BPA
-
#EULAR2019 En esclerosis sistémica el#riociguat podría tener efectos positivos en función pulmonar (énfasis en el PODRÍA) http://scientific.sparx-ip.net/archiveeular/index.cfm?c=a&searchfor=Op0183&view=1&item=2019OP0183 … -
Very important findings about the potential role of CYP1A enzymes (regulated by immunemodulatory transcription factor
#AhR) in rationalizing interparient variability of drug exposure.#Riociguat as the tip of the iceberg of a more general & underappreciated effect?@AcsMedihttps://twitter.com/FollmannMarkus/status/1115560157700939776 … -
Safety of riociguat for the treatment of pulmonary hypertension: Data from the EXPERT registry. https://buff.ly/2ByYQoF .
#papworthauthors#riociguat#pulmonaryhypertension -
Smaller right heart size and better right ventricular function have been observed in individuals with
#PAH or#CTEPH undergoing long-term#riociguat treatment. http://ow.ly/FQNX30nrmRa -
Prof. Oliver Distler interviewed on the results of the
#Riociguat in#SSc. Head to youtube for the full interview.@CosimoBruni@EUSTAR_org#ACR18 https://youtu.be/mqpKwkb7iH8 pic.twitter.com/lDIOMVVs2P
-
#Riociguat not for use in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/544350/DSU_August_2016.pdf … -
7 días...
@aziridinio habrá que crear el templo a#Riociguat pues es patrón ya de los#FIR.#PrayToRiociguatForFIRpic.twitter.com/kwjM40C1T4
-
Abstract from new
@BMC_series supplement http://buff.ly/1Q8i9V2 : The clinical development of#sGC modulators,#riociguat and#vericiguat -
#AEMPS_Publica IPT#Riociguat en#Hipertensión_pulmonar tromboembólica crónica http://ow.ly/Oa5u6@sefh_@safh_info@Sociedad_SEMI -
Scottish Medicines Consortium -
#riociguat approved 4 restricted use in CTEPH http://bit.ly/1woKdxC @BayerHealthCare#hypertension#cardio -
#Riociguat un respiro para la Hipertensión Arterial Pulmonar#HAP http://www.milenio.com/cultura/problemas_pulmonres-hipertension_pulmonar-asma-enfermedades_pulmonares_0_409159253.html … -
En México
#Riociguat única terapia en el mundo#HipertensiónPulmonar y la de tipo crónico no operable resistente/recurrente@BayerenMexico
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.